Pharma
On July 23, 2026, Navan, the AI-powered business travel and expense platform, announced that Evotec, the global drug discovery and development company headquartered in Hamburg, Germany (per Evotec's public company profile), has selected the platform to manage its complete corporate Travel and Expense (T&E) program across its top global markets.
“Simplifying processes and strengthening operational excellence while enabling our employees with efficient tools are key priorities for Evotec,” said Kay Prätorius, VP Procurement at Evotec. “Transitioning to the single, intuitive Navan platform will enhance the overall user experience, providing real-time visibility and control over our global travel and expense activities.”
According to the companies, Evotec had previously managed T&E independently by country, requiring employees to navigate different tools and manual offline processes in each market. The company said this fragmented approach is being replaced with a single platform intended to support consistency, transparency, and efficiency across its operations.
